2 ASX shares highly recommended to buy: Experts

Are these two stocks the best buys on the ASX?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I think it's a good idea to invest in undervalued ASX shares, as it gives us a greater chance of delivering pleasing returns. Analysts are always on the lookout for ideas that could be attractive and beat the market.

When one analyst thinks a business is a buy, that's interesting. It could be an excellent buying signal if numerous analysts think the business is a buy.

The two ASX shares I'm about to outline are two of the most buy-rated businesses out there.

A group of people push and shove through the doors of a store, trying to beat the crowd.

Image source: Getty Images

Coles Group Ltd (ASX: COL)

According to the CommSec collation of analyst opinions on Coles shares, there are currently 10 buys on the business.

Coles runs a national supermarket business as well as a liquor division that includes Coles Liquor, First Choice Liquor Market, Liquorland, and Vintage Cellars.

Coles has a number of advantages compared to many of its competitors, including scale, product range, online delivery, and geographic reach. It's doing so well in fact that its sales growth is currently outperforming Woolworths Group Ltd (ASX: WOW).

One of the brokers that recently reiterated that Coles is a buy is UBS.

UBS noted that Coles is putting effort into vertical integration in priority food categories such as meat, milk, and ready-to-eat meals (Chef Fresh). The facilities are close to and integrated with existing NSW supply chain infrastructure, including distribution centres and customer fulfilment facilities. Coles is confident it can lower end-to-end costs.

The broker noted that meat is at the centre of the plate, a key factor in how consumers perceive value. The facilities have also added shelf life at home. Fresh milk is an "important category in large customer baskets", and Coles has increased shelf life by two days.

UBS also pointed out that 'convenience' meals have grown 20% in the last two years, are an evolving category, and Coles can now innovate more quickly to meet these changing customer needs.

The broker has a price target of $25 for the business, implying a double-digit percentage rise from where it is today (at the time of writing).

Qantas Airways Ltd (ASX: QAN)

Australia's largest airline is another ASX share with numerous buy ratings on the business. There are currently 11 positive recommendations on the business, according to the CommSec collation of opinions.

UBS also rates Qantas as a buy. In its most recent note, the broker highlighted that the Australian international market is expected to grow capacity by 9% year over year. But unless passenger demand keeps pace, this could put pressure on market fares and/or load factors (plane utilisation).

Qantas is adding capacity to mainland US, New Zealand, Singapore, Bali, Thailand, and Hawaii. Jetstar is entering the Philippines.

UBS noted that Qantas is guiding that international RASK (revenue per available seat kilometre) could rise by between 2% to 3% in the first half of FY26, with the broker then projecting another 3% rise in the second half of FY26.

But the broker also noted that domestic demand is proving resilient, with 8% revenue growth expected in the first half of FY26, and the company and industry showing restraint in growing capacity too strongly. Loyalty continues to provide reliable earnings growth.

UBS maintains "some caution" about the rate of cost growth and the "medium term hump" in capital expenditure, which relates to fleet renewal.

The broker estimates Qantas could generate $1.79 billion of net profit in FY26, and it has a price target of $11.50 on the business.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Woolworths Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Broker Notes

5 ASX shares downgraded by brokers this week

Brokers reduced their ratings on Endeavour, APA Group, Guzman y Gomez, and other shares. 

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

Macquarie says these 3 ASX 200 stocks can return 38% to 93%

Three very different companies which could deliver outsized returns.

Read more »

Plane taking off from Sydney airport with CBD in background.
Broker Notes

Buy, hold, sell: Macquarie, Fortescue, Qantas shares

We review 3 fresh buy, hold, and sell calls from expert market analysts. 

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Broker says this ASX 200 stock could rocket 50%+ in 12 months

Bell Potter has good things to say about this stock.

Read more »

Broker Notes

2 ASX 200 stocks drawing fresh buy ratings this week 

These shares have solid upside.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »